Nonetheless, clearer delineation of the function of stromal Egr1 in peritoneal metastasis of GC should be explored through systemic Egr1 inhibition in genetically engineered mouse model of GC, and construction of conditional Egr1-null mice. This evidence concerns the gene EGR1 and gastric cancer.